Skip to main content
Digicann Ventures Inc. logo

Digicann Ventures Inc. — Investor Relations & Filings

Ticker · DCNN CSE Manufacturing
Open in API
Filings indexed 280 across all filing types
Latest filing 2020-04-30 Capital/Financing Update
Country CA Canada
Listing CSE DCNN

About Digicann Ventures Inc.

https://digicann.io/

Digicann Ventures Inc., formerly known as Agra Ventures Ltd., is a company focused on opportunities within the global cannabis industry. The company operates as a pharmaceutical entity, specializing in the manufacture and distribution of medical cannabis products and proprietary test kits. While primarily engaged in the sale of cannabis-related products, Digicann Ventures Inc. also explores strategic opportunities outside of the traditional cannabis sector.

Recent filings

Filing Released Lang Actions
News release - French.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release from AgraFlora Organics International Inc. dated April 30, 2020. It announces the closing of a private placement financing of 20 million dollars, issuance of shares to creditors for debt settlement, appointment of a new corporate secretary, and granting of stock options to directors, officers, and consultants. The content focuses on corporate updates related to financing and management changes but does not contain detailed financial statements or comprehensive financial performance data. It is not an annual or interim report, nor an earnings release or audit report. The primary focus is on capital raising and corporate updates, which fits the definition of a Capital/Financing Update (CAP). The document length is 5784 characters, sufficient to be a full announcement rather than a brief notice. Therefore, the appropriate classification is CAP with high confidence.
2020-04-30 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a news release from AgraFlora Organics International Inc. dated April 30, 2020. It announces the closing of a private placement financing, issuance of shares to creditors, appointment of a new Corporate Secretary, and granting of stock options. The content focuses on corporate updates related to financing and management changes but does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. The primary focus is on financing activities and a management appointment. Given the emphasis on the private placement and capital raising, the document fits best under Capital/Financing Update (CAP). The management appointment is secondary and does not dominate the document. The document length is over 5,000 characters and contains substantive information, so it is not a mere announcement of a report publication. Therefore, the classification is CAP with high confidence.
2020-04-30 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report, which is a regulatory filing used to disclose material changes in a company's business or operations. It includes details about a significant operational development (production of CBD oil and distillate by a subsidiary). The document is relatively short (2602 characters) and structured as a formal notification rather than a full financial or management report. It does not contain financial statements or detailed analysis, nor is it an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-04-24 English
News release - English.pdf
Capital/Financing Update Classification · 85% confidence The document is a news release announcing the completion of the first batch of CBD Oil and CBD Distillate by AgraFlora Organics International Inc. It provides operational updates about the company's subsidiary and its production achievements. There are no financial statements, detailed financial performance data, or regulatory filing references such as 10-K or interim reports. The document is a corporate announcement about product development and business progress rather than a formal financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. The content aligns best with a Capital/Financing Update (CAP) as it relates to business operations and product development announcements that could impact company valuation and investor interest, but it is not a direct financial result announcement. However, since it is primarily a news release about operational progress and product completion, the best fitting category is Capital/Financing Update (CAP).
2020-04-24 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the completion of the first batch of CBD oil and distillate by AgraFlora Organics International Inc. It contains no financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about operational progress and product development, not a financial report or regulatory filing. The document is not an Annual Report, Interim Report, Earnings Release, or any other financial or regulatory filing. It is a general corporate press release about business activities and product milestones. Therefore, it fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2020-04-24 English
News release - English.pdf
Report Publication Announcement Classification · 95% confidence The document is a news release from AgraFlora Organics International Inc. announcing an update to its annual filings due to a regulatory extension related to the COVID-19 pandemic. It references the delay in filing audited financial statements, management discussion and analysis (MD&A), and related officer certificates for the fiscal year ended December 31, 2019. The document does not contain the actual financial statements or MD&A but rather informs about the extension and the company's reliance on regulatory relief. It also mentions no material developments since the last interim financial statements. The document is essentially an announcement about the timing and status of annual filings, not the filings themselves. Therefore, it fits the category of a Report Publication Announcement (RPA) rather than an Annual Report (10-K) or Interim Report (IR).
2020-04-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.